A de novo heterozygous cardiac RYANODINE (cas 15662-33-6) receptor gene (RYR2) mutation in a catecholaminergic polymorphic ventricular tachycardia patient
-
Add time:09/09/2019 Source:sciencedirect.com
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is one of the most common causes of sudden cardiac death (SCD) during childhood and adolescence. A de novo heterozygous Glu2296Lys mutation in the RYANODINE (cas 15662-33-6) receptor 2 (RyR2) was identified in a 5-year-old boy with CPVT by whole exome sequencing (WES), and it was confirmed by Sanger sequencing. No mutation was found in his healthy parents. Neural network analysis predicted that a Glu2296Lys mutation could decrease the stability of the RYR2 protein, with a confidence score of −0.8831. A STRUM server prediction also confirmed that a Glu2296Lys mutation could reduce RYR2 protein stability. Thus, we confirmed that the Glu2296Lys mutation may play a critical role in the stability of RYR2, which is associated with CPVT. So, the de novo RYR2 mutation may cause CPVT in this patient, but further evidence is needed to prove causality.
We also recommend Trading Suppliers and Manufacturers of RYANODINE (cas 15662-33-6). Pls Click Website Link as below: cas 15662-33-6 suppliers
Prev:ArticleMapping RYANODINE (cas 15662-33-6) Binding Sites in the Pore Cavity of RYANODINE (cas 15662-33-6) Receptors
Next:Molecules in focusRYANODINE (cas 15662-33-6) receptor Ca2+ release channel post-translational modification: Central player in cardiac and skeletal muscle disease) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Molecules in focusRYANODINE (cas 15662-33-6) receptor Ca2+ release channel post-translational modification: Central player in cardiac and skeletal muscle disease09/10/2019
- ArticleMapping RYANODINE (cas 15662-33-6) Binding Sites in the Pore Cavity of RYANODINE (cas 15662-33-6) Receptors09/08/2019
- Basal RYANODINE (cas 15662-33-6) receptor activity suppresses autophagic flux09/07/2019
- RYANODINE (cas 15662-33-6) receptor dysfunction in human disorders☆09/06/2019
- Research paperStructural development of a type-1 RYANODINE (cas 15662-33-6) receptor (RyR1) Ca2+-release channel inhibitor guided by endoplasmic reticulum Ca2+ assay09/05/2019
- Synthesis, insecticidal evaluation and mode of action of novel anthranilic diamide derivatives containing sulfur moiety as potential RYANODINE (cas 15662-33-6) receptor activators09/04/2019
- Interaction of the Homer1 EVH1 domain and skeletal muscle RYANODINE (cas 15662-33-6) receptor09/03/2019
- ArticleInfluence of Lipid Mimetics on Gating of RYANODINE (cas 15662-33-6) Receptor09/02/2019
- A novel target for the promotion of dermal wound healing: RYANODINE (cas 15662-33-6) receptors09/01/2019